Related Experiment Videos
p53 expression in laryngeal carcinoma
G Boag1, C S Lee, D Charalambous
1Department of Anatomical Pathology, St Vincent's Hospital, Melbourne, Victoria.
Pathology
|October 1, 1993
Summary
The p53 protein, a nuclear phosphoprotein, was found in most laryngeal squamous cell carcinomas but rarely in benign lesions. This indicates p53 may contribute to larynx cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- The p53 protein is a nuclear phosphoprotein involved in cellular regulation.
- Squamous cell carcinoma is a common malignancy affecting various organs, including the larynx.
- Understanding the role of specific proteins like p53 in carcinogenesis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the expression of the p53 protein in laryngeal squamous cell carcinoma.
- To compare p53 expression levels between malignant and benign laryngeal lesions.
- To determine the potential role of p53 in the pathogenesis of laryngeal cancer.
Main Methods:
- Utilized immunohistochemistry with a polyclonal rabbit antibody (CM1) to detect p53 expression.
- Analyzed tissue samples from 21 cases of squamous cell carcinoma of the larynx.
- Examined 16 cases of benign laryngeal lesions as a control group.
Main Results:
- Nuclear staining for p53 was observed in 14 out of 21 (approximately 67%) laryngeal carcinomas.
- Only one out of 16 (approximately 6%) benign laryngeal lesions showed detectable p53 protein.
- A significant difference in p53 expression was noted between malignant and benign laryngeal tissues.
Conclusions:
- The elevated expression of p53 in laryngeal squamous cell carcinoma suggests its involvement in malignant transformation.
- Similar to its role in lung cancer, p53 may be a key factor in the development of larynx cancer.
- Further research into p53's function could lead to novel diagnostic markers or therapeutic strategies for laryngeal cancer.